The role of and indication for long-acting injectables is highlighted as a treatment approach for HIV. Adam C. Welch, PharmD, MBA: An evolving space is long-acting injectables. It sounds great: 1 ...

Long-acting injectables (LAIs) are sustained drug delivery systems specifically designed so that medication is released into the body gradually over an extended period of time. Image Credit: Powder ...

Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and two-drug regimens that could decrease toxicity associated with standard ...

Cabotegravir demonstrated efficacy as a long-acting PrEP, with no new HIV cases in the PILLAR trial over 12 months. The combination of cabotegravir and rilpivirine showed high viral suppression rates ...

Long-acting antiretroviral therapy (ART) for HIV involving injections every 1 or 2 months not only shows non-inferiority to a standard daily oral treatment regimen, it also suppresses HIV even in ...

Please provide your email address to receive an email when new articles are posted on . Long-acting ART for HIV is effective at helping people who do not adhere with daily oral ART achieve viral ...

New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations. By Apoorva Mandavilli A pill taken once a week. A shot ...